9,912 Shares in IDEX Corporation $IEX Purchased by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp purchased a new stake in shares of IDEX Corporation (NYSE:IEX) in the second quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 9,912 shares of the industrial products company’s stock, valued at approximately $2,250,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of IEX. BlackRock Inc. bought a new stake in shares of IDEX in the 2nd quarter worth approximately $1,301,393,000. Primecap Management Co. CA increased its position in IDEX by 86.5% during the 4th quarter. Primecap Management Co. CA now owns 3,226,787 shares of the industrial products company’s stock valued at $574,174,000 after buying an additional 1,496,207 shares in the last quarter. State Street Corp raised its stake in IDEX by 0.6% during the fourth quarter. State Street Corp now owns 3,172,410 shares of the industrial products company’s stock valued at $564,499,000 after buying an additional 17,668 shares during the last quarter. Geode Capital Management LLC boosted its holdings in IDEX by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 2,034,942 shares of the industrial products company’s stock worth $360,740,000 after acquiring an additional 7,844 shares in the last quarter. Finally, Van ECK Associates Corp boosted its holdings in IDEX by 3.3% in the fourth quarter. Van ECK Associates Corp now owns 1,976,856 shares of the industrial products company’s stock worth $351,762,000 after acquiring an additional 63,699 shares in the last quarter. Hedge funds and other institutional investors own 97.96% of the company’s stock.

IDEX Stock Performance

Shares of NYSE IEX opened at $234.91 on Thursday. IDEX Corporation has a 1 year low of $158.19 and a 1 year high of $243.80. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.05 and a quick ratio of 2.15. The stock has a market cap of $17.32 billion, a PE ratio of 33.80, a price-to-earnings-growth ratio of 2.17 and a beta of 0.98. The firm has a fifty day moving average price of $228.47 and a 200-day moving average price of $213.48.

IDEX (NYSE:IEX) last posted its quarterly earnings results on Wednesday, July 29th. The industrial products company reported $2.32 EPS for the quarter, beating analysts’ consensus estimates of $2.11 by $0.21. The business had revenue of $920.60 million for the quarter, compared to analysts’ expectations of $905.38 million. IDEX had a return on equity of 15.69% and a net margin of 14.49%.The business’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period last year, the firm earned $2.07 earnings per share. IDEX has set its FY 2026 guidance at 8.700-8.850 EPS and its Q3 2026 guidance at 2.200-2.250 EPS. Equities analysts anticipate that IDEX Corporation will post 8.82 earnings per share for the current fiscal year.

IDEX Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, July 24th. Shareholders of record on Monday, July 6th were paid a $0.73 dividend. The ex-dividend date was Monday, July 6th. This represents a $2.92 annualized dividend and a yield of 1.2%. IDEX’s payout ratio is presently 42.01%.

Insider Activity at IDEX

In related news, CAO Lisa M. Anderson sold 385 shares of the business’s stock in a transaction dated Wednesday, August 12th. The stock was sold at an average price of $238.59, for a total value of $91,857.15. Following the sale, the chief accounting officer directly owned 4,327 shares in the company, valued at approximately $1,032,378.93. The trade was a 8.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.50% of the company’s stock.

Key Headlines Impacting IDEX

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: Zacks increased its FY2026 EPS estimate to $8.71 from $8.70, Q4 2026 to $2.20 from $2.18, and Q1 2027 to $2.12 from $2.11.
• Positive Sentiment: Longer-term estimates also improved: FY2027 EPS rose to $9.26 from $9.21, Q4 2027 to $2.42 from $2.38, Q1 2028 to $2.38 from $2.36, and FY2028 to $10.54 from $10.45. The revisions imply continued earnings growth, although the increases were relatively small.
• Positive Sentiment: The revised FY2026 estimate of $8.71 remains close to the broader analyst consensus of $8.82. IDEX’s latest reported quarter also showed earnings and revenue ahead of expectations, with EPS of $2.32 and revenue of $920.6 million, up 6.4% year over year.
• Neutral Sentiment: The six Zacks updates largely repeat the same forecast changes rather than representing separate fundamental developments. Investors may view them as supportive, but the limited size of the revisions may constrain their impact.
• Neutral Sentiment: IDEX shares have increased and are trading near the upper end of their 52-week range, above both their 50-day and 200-day moving averages. With a market capitalization of approximately $17.3 billion and a forward-looking valuation near 27 times earnings, further gains may depend on the company converting the raised forecasts into actual results.
• Neutral Sentiment: A separate report concerns IDEX Biometrics ASA (OTC: IDXAF), which granted incentive subscription rights to two senior employees. That company is unrelated to IDEX Corporation and should not affect IEX shares. IDEX Biometrics executive incentive rights announcement

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Oppenheimer restated an “outperform” rating and set a $265.00 price target on shares of IDEX in a report on Thursday, July 30th. Mizuho upgraded shares of IDEX from a “neutral” rating to an “outperform” rating and upped their price target for the stock from $210.00 to $280.00 in a research note on Tuesday, August 11th. TD Cowen increased their price target on shares of IDEX from $260.00 to $275.00 and gave the company a “buy” rating in a report on Thursday, July 30th. Seaport Research Partners reaffirmed a “buy” rating and set a $250.00 price objective on shares of IDEX in a research report on Tuesday, May 5th. Finally, Weiss Ratings raised shares of IDEX from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, July 30th. Eight equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $260.80.

IDEX Company Profile

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.